Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of FX006 in Knee Osteoarthritis
NCT02637323Phase 2Completed
- Sponsor
- Pacira BioSciences
- Start
- Nov 2015
- Primary completion
- Sep 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of triamcinolone acetonide in osteoarthritis (OA), sponsored by Pacira BioSciences. Started Nov 2015; status: completed.
02
Drugs
triamcinolone acetonide
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02637323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02637323.